Watch: No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors Dr. Mike Putman discusses abstract 1071 with Dr. Madeline O'Sullivan at the 2023 ACR Convergence meeting in San Diego, CA. https://t.co/YdIlhLf5gh https://t.co/6dfWHakboh

ACR Daily Recap - MONDAY Panelists: Drs. Kathryn Dao, Michael Putman and Eric Dein Moderator: Dr. Jack Cush https://t.co/b1k1gsHI2z https://t.co/BWu7GXFxhj

IgG4 disease- the WInS withdrawal study results https://t.co/rg0YJ0LlZM https://t.co/L6SzcD7QlJ

Theres a ustekinumab biosimilar, CT-P43 - In a multinational, phase III study in 509 plaque psoriasis pts, CT-P43 was equivalent to the originator, Stelara, with week 16 PASI75 scores of 78% vs 76%, and continued efficacy out to week 40 https://t.co/dEImEp8l90 https://t.co/UoqGgaad8H

FDA issued a safety alert for BCMA- or CD19- Autologous CAR-T cell Immunotherapies; they've received reports & are investigating Risk of T-cell Malignancy (CAR-positive lymphoma) occuring in several products w/in this class (most for Cancer use) https://t.co/RpBhcGarGy https://t.co/mDuXmVW4Fz

Rheumatoid Arthritis Topic Podcast https://t.co/ClEuz2bVzA https://t.co/19jZhSt3Dc

Does GnRHa Reduce Premature Ovarian Insufficiency in SLE Patients on Cyclophosphamide? https://t.co/GVk2KLoGYq https://t.co/Hv9Bcn8cLg

Why are older RA patients getting mistreated? Most rheums would say that every RA patient should be started on a DMARD. So I'm shocked that, in a US Medicare 20% sample dataset b/w 2008-17, less than 30% of new RA patients aged 66+ have a DMARD initiated. https://t.co/VFp3oz8wGK https://t.co/60Jn6ShmDs

Do We Stop or Continue Treatment? Remission had been a dream, an elusive concept. But then, with the introduction of biologics, conventional synthetic and targeted synthetic DMARDS, patients are able to live longer and with a better quality of life. https://t.co/qSgfuDvAQb https://t.co/eUzIaC35tl

WATCH: TMP SMX Prophylaxis in GPA https://t.co/JtIjgxwrCf https://t.co/Tmzdu00oyH

The SMART Study: Split Dose Oral Methotrexate Dr. Jack Cush discusses abstract 1583 presented at the 2023 ACR Convergence meeting in San Diego. https://t.co/Blg4EUe5rX https://t.co/0svgLAZ1as

An Interview with Kevin Winthrop: Three Questions About COVID 19 Drs. Jack Cush and Kevin Winthrop discuss COVID 19 at 2023 ACR Convergence in San Diego, CA. https://t.co/UL8q356G3i https://t.co/wWsEHz9obA